Editorial: Gene-based renaming of human diseases.
作者信息
Marian Ali J
机构信息
Center for Cardiovascular Genetics, Institute of Molecular Medicine, The University of Texas Health Science Center. Houston, Texas, USA.
出版信息
Curr Opin Cardiol. 2024 May 1;39(3):135-137. doi: 10.1097/HCO.0000000000001123. Epub 2024 Apr 4.
Abstract
摘要
相似文献
1
Editorial: Gene-based renaming of human diseases.社论：基于基因的人类疾病重新命名
Curr Opin Cardiol. 2024 May 1;39(3):135-137. doi: 10.1097/HCO.0000000000001123. Epub 2024 Apr 4.
2
Associations between renaming schizophrenia and stigma-related outcomes: A systematic review.精神分裂症命名与耻辱感相关结局之间的关联：系统综述。
Psychiatry Clin Neurosci. 2017 Jun;71(6):347-362. doi: 10.1111/pcn.12510. Epub 2017 Mar 19.
3
Renaming schizophrenia: why, how, and what next?重新命名精神分裂症：为何、如何以及接下来做什么？
Curr Opin Psychiatry. 2025 May 1;38(3):147-153. doi: 10.1097/YCO.0000000000001002. Epub 2025 Mar 11.
4
Renaming Schizophrenia and Stigma Reduction: A Cross-Sectional Study of Nursing Students in Taiwan.精神分裂症更名与减少污名化：台湾护理学生的横断面研究。
Int J Environ Res Public Health. 2022 Mar 17;19(6):3563. doi: 10.3390/ijerph19063563.
5
Renaming schizophrenia: a Japanese perspective.重新命名精神分裂症：日本视角
World Psychiatry. 2006 Feb;5(1):53-5.
6
Letter from the editor: renaming the journal Human Vaccines & Immunotherapeutics.编辑来信：《人类疫苗与免疫疗法》杂志更名
Hum Vaccin. 2011 Oct;7(10):993. doi: 10.4161/hv.7.10.18259.
7
Editorial: Renaming low risk prostate cancer: proceed cautiously.社论：重新命名低风险前列腺癌：谨慎行事。
Can J Urol. 2012 Feb;19(1):6069.
8
Change in newspaper coverage of schizophrenia in Japan over 20-year period.日本20年间报纸对精神分裂症报道的变化。
Schizophr Res. 2016 Aug;175(1-3):193-197. doi: 10.1016/j.schres.2016.04.026. Epub 2016 May 11.
9
Data-mining analysis of media frame effects on social perception of schizophrenia renaming in Korea.对韩国精神分裂症更名过程中媒体框架效应的社会感知进行数据挖掘分析。
BMC Psychiatry. 2023 Nov 27;23(1):882. doi: 10.1186/s12888-023-05386-4.
10
Renaming schizophrenia to reduce stigma: comparison with the case of bipolar disorder.将精神分裂症重新命名以减少污名化：与双相情感障碍的情况比较。
Br J Psychiatry. 2015 Apr;206(4):341-2. doi: 10.1192/bjp.bp.114.146217. Epub 2015 Jan 8.
引用本文的文献
1
Phenotypic diversity of the LMNA mutations.LMNA 突变的表型多样性。
Curr Opin Cardiol. 2025 May 1;40(3):126-130. doi: 10.1097/HCO.0000000000001205. Epub 2025 Apr 3.
本文引用的文献
1
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.扩张型心肌病：病因、发病机制及当前和未来的治疗方法。
Lancet. 2023 Sep 16;402(10406):998-1011. doi: 10.1016/S0140-6736(23)01241-2.
2
Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies.安德森-法布里病心肌病：流行病学、诊断方法、管理及监测策略的最新进展
Front Cardiovasc Med. 2023 Jun 2;10:1152568. doi: 10.3389/fcvm.2023.1152568. eCollection 2023.
3
PANoptosis is a prominent feature of desmoplakin cardiomyopathy.全细胞程序性坏死是桥粒斑蛋白心肌病的一个显著特征。
J Cardiovasc Aging. 2023 Feb;3(1). doi: 10.20517/jca.2022.34. Epub 2023 Jan 1.
4
The impact of genetics on the long QT syndrome: myth or reality?遗传学对长QT综合征的影响：神话还是现实？
Curr Opin Cardiol. 2023 May 1;38(3):149-156. doi: 10.1097/HCO.0000000000001027. Epub 2023 Jan 30.
5
A combinatorial oligogenic basis for the phenotypic plasticity between late-onset dilated and arrhythmogenic cardiomyopathy in a single family.一个家族中迟发性扩张型心肌病和致心律失常性心肌病之间表型可塑性的组合寡基因基础。
J Cardiovasc Aging. 2021;1. doi: 10.20517/jca.2021.15. Epub 2021 Sep 3.
6
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.马卡丹特治疗非梗阻性肥厚型心肌病有症状患者的疗效评估。
J Am Coll Cardiol. 2020 Jun 2;75(21):2649-2660. doi: 10.1016/j.jacc.2020.03.064.
7
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.桥粒斑蛋白心肌病，一种与典型扩张型或致心律失常性右室心肌病不同的纤维性和炎症性心肌病。
Circulation. 2020 Jun 9;141(23):1872-1884. doi: 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6.
8
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.致心律失常性右室心肌病的定义与治疗：更新的专家小组报告。
Eur J Heart Fail. 2019 Aug;21(8):955-964. doi: 10.1002/ejhf.1534. Epub 2019 Jun 18.
9
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
10
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.肥厚型心肌病：遗传学、发病机制、临床表现、诊断与治疗
Circ Res. 2017 Sep 15;121(7):749-770. doi: 10.1161/CIRCRESAHA.117.311059.
Zotero 插件